NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Angiogenesis



New angiogenesis research has been reported by scientists at Gunma University, Medical Department



June 30th, 2009

According to a study from Gunma, Japan, "L-[3-F-18]-alpha-methyltyrosine (F-18-FMT) is an amino-acid tracer for positron-emission tomography (PET). We have conducted a clinicopathologic study to elucidate the correlation of angiogenesis with F-18-FMT and 2-[F-18]-fluoro-2-deoxy-D-glucose (F-18-FDG) uptake in patients with non-small cell lung cancer (NSCLC)."

"Thirty-seven NSCLC patients were enrolled in this study, and two PET studies with F-18-FMT and F-18-FDG were performed. Uptake of PET tracers was evaluated with standardized uptake value. Vascular endothelial growth factor (VEGF), CD31, CD34, L-type amino acid transporter 1 (LAT1) and Ki-67 labeling index of the...


Source: Cancer Weekly (2009-06-30)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login